News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Daily News Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes Caitlin E. Cox November 03, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Conference News HFSA 2021 Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF Michael O'Riordan September 14, 2021
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Daily News One in Six HF Patients Delay or Forego Care, Inflating Costs Shelley Wood August 12, 2021
News Conference News TVT 2021 Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’ Todd Neale July 27, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Conference News ACC 2021 Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics L.A. McKeown May 24, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News EHRA 2021 RACE 3: Effects Wane for Targeted Therapy in Early AF, HF Todd Neale April 26, 2021
News Daily News Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes Shelley Wood April 13, 2021
News Daily News Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key Michael O'Riordan March 16, 2021
News Conference News STS 2021 Surgeons More Likely to Stray From CABG Best Practices in Female Patients Caitlin E. Cox February 03, 2021
News Daily News Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients Michael O'Riordan February 01, 2021
News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021
News Daily News ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care L.A. McKeown January 11, 2021